Ajanta Pharma Limited — Cefixime Exporter Profile
Indian Pharmaceutical Exporter · #12 for Cefixime · $2.9M export value · DGFT Verified
Ajanta Pharma Limited is the #12 Indian exporter of Cefixime with $2.9M in export value and 63 verified shipments. Ajanta Pharma Limited holds a 1.7% market share in Cefixime exports across 5 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Cefixime Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Cefixime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $1.8M | 49 | 92.5% |
| FRANCE | $147.3K | 11 | 7.5% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $15 | 1 | 0.0% |
| MALI | $0 | 1 | 0.0% |
| COTE D IVOIRE | $0 | 1 | 0.0% |
Ajanta Pharma Limited exports Cefixime to 5 countries. The largest destination is IRAQ accounting for 92.5% of Ajanta Pharma Limited's Cefixime shipments, followed by FRANCE (7.5%) and CONGO, THE DEMOCRATIC REPUBLIC OF THE (0.0%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefixime from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| KAWKAB SCIENTIFIC BUREAU | IRAQ | $1.0M | 24 |
| HAWKARY PHARMACEUITCAL CO. | IRAQ | $674.7K | 22 |
| PLANET PHARMA SA | FRANCE | $147.3K | 11 |
| HAWKARY PHARMACEUITCAL CO | IRAQ | $128.4K | 3 |
| BAITH PHARMA | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $15 | 1 |
| PROMOPHARMA | MALI | $0 | 1 |
| NOBEL PHARMA | COTE D IVOIRE | $0 | 1 |
Ajanta Pharma Limited supplies Cefixime to 7 buyers globally. The largest buyer is KAWKAB SCIENTIFIC BUREAU (IRAQ), followed by HAWKARY PHARMACEUITCAL CO. (IRAQ) and PLANET PHARMA SA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefixime Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $61.9M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. Ajanta Pharma Limited contributes $2.9M to this total, accounting for 1.7% of India's Cefixime exports. Ajanta Pharma Limited ships Cefixime to 5 countries through 7 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Cefixime Exports?
Ajanta Pharma Limited's average Cefixime shipment value is $46.0K per consignment, based on 63 shipments totaling $2.9M. The largest destination is IRAQ (92.5% of Ajanta Pharma Limited's Cefixime exports).
How Does Ajanta Pharma Limited Compare to Other Indian Cefixime Exporters?
Ajanta Pharma Limited ranks #12 among 668 Indian Cefixime exporters with a 1.7% market share. The top 3 exporters are MICRO LABS LIMITED ($19.1M), AUROBINDO PHARMA LTD ($8.0M), SAKAR HEALTHCARE LIMITED ($4.5M). Ajanta Pharma Limited processed 63 shipments to 5 destination countries.
What Cefixime Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FIXIM 400 CAPSULES[243330PAC X 1 X 6 = 1459980 CAPSULES][CEFIXIME TABLETS USP 400 MG] CONTAIN :AS PER INVOICENOS | $150.0K | 3 |
| FIXIM 400 CAPSULES[245080 X 1 X 6 = 1470480 CAPSULES][CEFIXIME TABLETS USP 400 MG]CONT:AS PER INVOICE | $150.0K | 3 |
| SHIPMENT UNDER CONSIGNMENT SALE:FIXIM PFOS 100MG/5ML-60ML[94490X1=94490BTLS]CEFIXIME FOR ORAL SUSPENSION USP 100MG/5ML]NOS | $79.1K | 3 |
| FIXIM 400 CAPSULES[81680X1X6=490080 CAPSULES][CEFIXIME TABLETS USP 400 MG] [EACHFILM COATED TABLET CONT:AS PER INVOICE] | $64.5K | 3 |
| FIXIM 400 CAPSULES[81330PAC X 1 X 6 = 487980 CAPSULES][CEFIXIME TABLETS USP 400MG]CONT:AS PER INVOICE | $64.4K | 3 |
| FIXIM 400 CAPSULES[80460PAC X 1 X 6 = 482760 CAPSULES][CEFIXIME TABLETS USP 400MG]CONT:AS PER INVOICE | $63.4K | 3 |
| FIXIM PFOS 100MG/5ML-30ML[CEFIXIME FOR ORAL SUSPENSION USP 100 MG/5 ML] [COMPOSITION TITLE :AS PER INVOICE] | $51.2K | 2 |
| SIPRAX CAPSULES 400MG 98100PAC X 1 X 6 588600 CAPSULES CEFIXIME CAPSULES 400MG CONT AS PER INVOICE | $50.0K | 1 |
| SIPRAX CAPSULES 400MG 98050PAC X 1 X 6 588300 CAPSULES CEFIXIME CAPSULES 400MG | $50.0K | 1 |
| SHIPMENT UNDER CONSIGNMENT SALE:FIXIM PFOS 100MG/5ML-60ML[94500X1=94500BOTTLE]CEFIXIME FOR ORAL SUSPENSION USP 100MG/5ML | $50.0K | 1 |
Ajanta Pharma Limited exports 49 distinct Cefixime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FIXIM 400 CAPSULES[243330PAC X 1 X 6 = 1459980 CAPSULES][CEF with 3 shipments worth $150.0K.
How Does Ajanta Pharma Limited Compare to Nearest Cefixime Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | CAPLIN POINT LABORATORIES LIMITED | $3.5M | 98 | 8 | $35.5K |
| 10 | MACLEODS PHARMACEUTICALS LTD | $3.3M | 65 | 9 | $50.0K |
| 12 | AJANTA PHARMA LIMITED ★ | $2.9M | 63 | 5 | $46.0K |
| 14 | AUROBINDO PHARMA LIMITED | $2.7M | 76 | 4 | $35.6K |
| 4 | UNIVENTIS MEDICARE LIMITED | $2.5M | 50 | 1 | $50.0K |
Ajanta Pharma Limited ranks #12 among 668 Indian Cefixime exporters. Average shipment value of $46.0K compared to the market average of $92.6K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Cefixime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 924 | 11.0% |
| JNPT | 498 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 480 | 5.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 449 | 5.3% |
| SAHAR AIR | 412 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 399 | 4.8% |
| DELHI AIR | 366 | 4.4% |
| AHEMDABAD ICD | 226 | 2.7% |
What Other Advanced Antibiotics Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Cefixime Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Cefixime, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefixime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 63 individual customs records matching Ajanta Pharma Limited exporting Cefixime, covering 49 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefixime Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Cefixime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Cefixime Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current shipment-level data, contact TransData Nexus.